FROM Dan Burk
Genetic Breakthroughs: Patents and Profits Mapping the human genome began "the biological gold rush of the 21st Century," with companies now owning patents on 4000 human genes. Today, the US Supreme Court is being asked to strike down two patents on BRCA 1 and BRCA 2, genes that helped doctors discover both breast and ovarian cancer. Nobody can do that without paying Myriad Genetics , which isolated the genes. But opponents argue the genes are "products of Nature." We hear about a case with long-term implications for the future of "personalized medicine" designed to serve the needs of each individual patient.
Does 'hire American' mean fire a foreigner? US companies are allowed to hire employees from other countries with highly developed skills that can't be found here. President Trump says it's being abused as a way to find cheap foreign labor. We hear about the benefits—and the risks—of changing the H-1B program.
Will the march for science politicize objective research? Protesters are gathering all over the country for tomorrow's Earth Day March for Science. Since President Trump has proposed massive cuts in basic scientific research, will the movement be perceived as partisan politics — whether scientists themselves like it or not?
White House flip flops: NATO, Syria and China In less than 100 days, President Trump has contradicted himself on a host of foreign policy issues — Syria, NATO, China and Vladimir Putin’s Russia. Is it a strength — or a weakness — for the United States when the world of power politics never knows what to expect?